Real Estate
Why Pharma Companies are Flocking to Hyderabad for R&D
CBRE's 'Global Life Sciences Atlas' highlights why Hyderabad is becoming a top destination for pharmaceutical research and development. The city's strategic advantages are attracting global pharma giants, making it a hub for innovation and growth in the healthcare sector.
Real Estate
Why Pharma Companies are Flocking to Hyderabad for R&D
CBRE's 'Global Life Sciences Atlas' highlights why Hyderabad is becoming a top destination for pharmaceutical research and development. The city's strategic advantages are attracting global pharma giants, making it a hub for innovation and growth in the healthcare sector.
Real Estate
Hyderabad: A Global Hub for Life Sciences Manufacturing
Hyderabad has emerged as a leading global center for life sciences manufacturing, with a record-breaking 10 million square feet of dedicated space in 2024. CBRE, the world's leading real estate consulting firm, highlights the city's significant growth in its latest report.
Real Estate
Hyderabad: A Global Hub for Life Sciences Manufacturing
Hyderabad has emerged as a leading global center for life sciences manufacturing, with a record-breaking 10 million square feet of dedicated space in 2024. CBRE, the world's leading real estate consulting firm, highlights the city's significant growth in its latest report.
real estate news
Nexpoint Real Estate Finance Surpasses Q1 2025 EPS Expectations, Stock Temporarily Dips
Nexpoint Real Estate Finance Inc (NREF) has announced its first-quarter 2025 financial results, surpassing earnings per share (EPS) forecasts. Despite the positive news, the stock experienced a slight dip, raising questions among investors. The company's strategic focus on life science leasing has been particularly notable in this quarter's performance.
real estate news
Alexandria Real Estate Stock Plummets to 52-Week Low: A Closer Look
The Alexandria Real Estate Equities, Inc., a company with a market cap of $13.26 billion, has seen its stock hit a 52-week low of $76.49. However, the company continues to offer a robust 6.79% dividend yield and has a history of increasing dividends for 14 consecutive years, making it an intriguing investment opportunity despite recent market volatility.